Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Morgan Stanley (MS)

Morgan Stanley (MS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders. It is valued at a market cap of $37.3 billion. 

This healthcare company has outperformed the broader market over the past 52 weeks. Shares of RMD have rallied 12.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 11.9%. Moreover, on a YTD basis, the stock is up 8.3%, compared to SPX’s marginal drop. 

Fundamentals

See More
  • Market Capitalization, $K 280,656,064
  • Shares Outstanding, K 1,589,309
  • Annual Sales, $ 70,645 M
  • Annual Income, $ 16,861 M
  • EBIT $ 21,954 M
  • EBITDA $ 27,115 M
  • 60-Month Beta 1.20
  • Price/Sales 2.28
  • Price/Cash Flow 14.90
  • Price/Book 2.70

Options Overview Details

View History
  • Implied Volatility 34.42% (+2.62%)
  • Historical Volatility 32.45%
  • IV Percentile 86%
  • IV Rank 25.96%
  • IV High 71.89% on 04/08/25
  • IV Low 21.28% on 08/26/25
  • Expected Move (DTE 7) 6.20 (3.55%)
  • Put/Call Vol Ratio 0.87
  • Today's Volume 10,607
  • Volume Avg (30-Day) 18,575
  • Put/Call OI Ratio 1.47
  • Today's Open Interest 389,488
  • Open Int (30-Day) 342,671
  • Expected Range 168.17 to 180.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.89
  • Number of Estimates 7
  • High Estimate 3.17
  • Low Estimate 2.52
  • Prior Year 2.60
  • Growth Rate Est. (year over year) +11.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.59 +6.59%
on 02/13/26
188.68 -7.58%
on 02/03/26
-14.72 (-7.78%)
since 01/16/26
3-Month
155.23 +12.33%
on 11/21/25
192.68 -9.50%
on 01/16/26
+12.08 (+7.44%)
since 11/19/25
52-Week
94.33 +84.85%
on 04/07/25
192.68 -9.50%
on 01/16/26
+33.68 (+23.94%)
since 02/19/25

Most Recent Stories

More News
Morgan Stanley Schedules Fourth Quarter and Full-Year 2026 Investor Conference Call

Morgan Stanley (NYSE: MS) will announce its fourth quarter and full-year 2026 financial results on Thursday, January 14, 2027, at approximately 7:30 a.m. (ET). A conference call to discuss the results...

MS : 174.37 (-1.26%)
Morgan Stanley Wealth Management Reduces Fees on Private Shares Marketplace EquityZen, Broadening Private Markets Access

Buy and Sell Side Fees Reduced to 2.5% for Investors and Shareholders

MS : 174.37 (-1.26%)
1 S&P 500 Stock on Our Buy List and 2 We Ignore

1 S&P 500 Stock on Our Buy List and 2 We Ignore

JKHY : 161.14 (+1.50%)
MS : 174.37 (-1.26%)
WAT : 328.66 (+0.35%)
ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

As ResMed has outpaced the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

$SPX : 6,861.89 (-0.28%)
MS : 174.37 (-1.26%)
RMD : 256.29 (-1.01%)
IHI : 59.12 (-0.56%)
Are Wall Street Analysts Predicting Equinix Stock Will Climb or Sink?

Equinix has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 6,861.89 (-0.28%)
MS : 174.37 (-1.26%)
EQIX : 918.03 (-0.67%)
SRVR : 32.80 (+0.06%)
Tony Clark resigns as MLB players' union head as possible cap fight looms

Tony Clark has resigned as head of the Major League Baseball Players Association, the union announced said, as a possible salary cap fight looms during a federal investigation of its finances

MS : 174.37 (-1.26%)
US stocks edge higher after swinging through worries about AI and the economy

A quiet finish for U.S. stocks masked big swings underneath the surface

NFLX : 77.00 (-1.27%)
META : 644.78 (+0.24%)
GOOGL : 302.85 (-0.16%)
NVDA : 187.90 (-0.04%)
AAPL : 260.58 (-1.43%)
BAC : 52.77 (-1.11%)
$SPX : 6,861.89 (-0.28%)
MS : 174.37 (-1.26%)
$IUXX : 24,797.34 (-0.41%)
GIS : 44.80 (-1.23%)
MSFT : 398.46 (-0.29%)
TSLA : 411.71 (+0.09%)
Morgan Stanley Investment Management Closes Revolving and Rated Private Securitization Backed by Consumer Loans

Approximately $220 million total loan purchase capacity estimated

MS : 174.37 (-1.26%)
Morgan Stanley Real Estate Investing Completes Sale of Spring Arbor Senior Living Portfolio for $296 Million

Morgan Stanley Investment Management, through funds managed by Morgan Stanley Real Estate Investing (MSREI), and Foundry Commercial (Foundry) announced today the sale of the final 11 communities in the...

MS : 174.37 (-1.26%)
Bunge Global Stock Outlook: Is Wall Street Bullish or Bearish?

Bunge Global has notably outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

BG : 123.49 (+1.41%)
$SPX : 6,861.89 (-0.28%)
MS : 174.37 (-1.26%)
MOO : 86.16 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Morgan Stanley, being the leading financial services holding company, serves corporations, governments, FIs & individuals world wide. It has 3 business units. The Institutional Securities unit includes capital raising, financial advisory services on mergers & acquisitions, restructurings, real estate...

See More

Key Turning Points

3rd Resistance Point 180.01
2nd Resistance Point 178.14
1st Resistance Point 176.26
Last Price 174.37
1st Support Level 172.51
2nd Support Level 170.64
3rd Support Level 168.76

See More

52-Week High 192.68
Last Price 174.37
Fibonacci 61.8% 155.11
Fibonacci 50% 143.51
Fibonacci 38.2% 131.90
52-Week Low 94.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar